APA (7th ed.) Citation

L, Z., C, C., B, L., K, Y., L, F., JL, F., . . . C, D. (2014). ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. Molecular cancer therapeutics, 13(5), 1345. https://doi.org/10.1158/1535-7163.MCT-13-1033

Chicago Style (17th ed.) Citation

L, Zhang, et al. "ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models." Molecular Cancer Therapeutics 13, no. 5 (2014): 1345. https://doi.org/10.1158/1535-7163.MCT-13-1033.

MLA (9th ed.) Citation

L, Zhang, et al. "ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models." Molecular Cancer Therapeutics, vol. 13, no. 5, 2014, p. 1345, https://doi.org/10.1158/1535-7163.MCT-13-1033.